Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-08 11:46 am Purchase | 2025-11-28 | 13G | Pasithea Therapeutics Corp. KTTA | JANUS HENDERSON GROUP PLC JHG | 10,229,652 9.990% | 10,229,652 (New Position) | Filing History |
| 2025-12-05 4:10 pm Purchase | 2025-11-28 | 13G | Pasithea Therapeutics Corp. KTTA | Squadron Master Fund LP | 2,252,930 9.900% | 2,252,930 (New Position) | Filing History |
| 2025-12-05 4:00 pm Purchase | 2025-12-01 | 13G | Pasithea Therapeutics Corp. KTTA | Vivo Opportunity Fund Holdings, L.P. | 17,560,467 9.990% | 17,560,467 (New Position) | Filing History |
| 2025-08-14 2:01 pm Purchase | 2025-06-30 | 13G | Pasithea Therapeutics Corp. KTTA | CVI Investments, Inc. | 826,145 9.900% | 198,826 (+31.69%) | Filing History |
| 2025-05-15 3:36 pm Purchase | 2025-03-31 | 13G | Pasithea Therapeutics Corp. KTTA | Armistice Capital, LLC | 142,082 4.990% | 8,295 (+6.20%) | Filing History |
| 2025-05-12 4:08 pm Purchase | 2025-05-06 | 13G | Pasithea Therapeutics Corp. KTTA | Mitchell P. Kopin | 317,863 4.990% | 317,863 (New Position) | Filing History |
| 2025-05-12 10:07 am Purchase | 2025-05-06 | 13G | Pasithea Therapeutics Corp. KTTA | CVI Investments, Inc. | 627,319 9.900% | 627,319 (New Position) | Filing History |
| 2025-05-09 4:36 pm Sale | 2025-05-07 | 13G | Pasithea Therapeutics Corp. KTTA | Orca Capital AG | 362,857 4.900% | -8,285 (-2.23%) | Filing History |
| 2025-05-09 4:31 pm Purchase | 2025-05-06 | 13G | Pasithea Therapeutics Corp. KTTA | Orca Capital AG | 371,142 5.700% | 371,142 (New Position) | Filing History |
| 2025-03-06 9:55 pm Purchase | 2025-03-01 | 13D | Pasithea Therapeutics Corp. KTTA | STEINMAN LAWRENCE | 83,858 3.100% | 83,858 (New Position) | Filing History |
| 2025-02-14 5:50 pm Purchase | 2024-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | Armistice Capital, LLC | 133,787 9.990% | 17,907 (+15.45%) | Filing History |
| 2024-11-14 3:32 pm Purchase | 2024-09-30 | 13G | Pasithea Therapeutics Corp. KTTA | Armistice Capital, LLC | 115,880 9.990% | 115,880 (New Position) | Filing History |
| 2023-06-07 6:29 pm Purchase | 2023-06-02 | 13D | Pasithea Therapeutics Corp. KTTA | STEINMAN LAWRENCE | 78,859 6.000% | 78,859 (New Position) | Filing History |
| 2023-02-14 6:28 pm Unchanged | 2022-10-22 | 13G | Pasithea Therapeutics Corp. KTTA | Paul B Manning | 170,435 11.300% | 0 (Unchanged) | Filing History |
| 2023-01-13 08:02 am Sale | 2022-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | Khire Uday | 61,405 4.600% | -12,228 (-16.61%) | Filing History |
| 2023-01-10 3:55 pm Sale | 2023-01-10 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 0 0.000% | -89,421 (Position Closed) | Filing History |
| 2022-12-13 7:26 pm Unchanged | 2022-12-09 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 89,421 6.100% | 0 (Unchanged) | Filing History |
| 2022-11-01 5:28 pm Purchase | 2022-10-31 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 89,421 6.700% | 4,305 (+5.06%) | Filing History |
| 2022-10-20 11:11 am Purchase | 2022-10-11 | 13G | Pasithea Therapeutics Corp. KTTA | Khire Uday | 73,633 5.000% | 73,633 (New Position) | Filing History |
| 2022-09-06 4:10 pm Purchase | 2022-09-02 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 85,116 6.400% | 3,358 (+4.11%) | Filing History |